Advanced Drug Delivery Market to Grow 10.2% Annually Through 2030

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

• The enteral route of administration will continue to dominate the market through the end of 2030

  80% confidence

• Nanotechnology enables precise targeting and controlled drug release, improving solubility and bioavailability while reducing side effects

  80% confidence

• The Asia-Pacific region shows the highest CAGR

  80% confidence

• The advanced drug delivery systems market is projected to grow from $299.6 billion in 2025 to $487.4 billion by the end of 2030

  80% confidence

• North America will continue to dominate the market through the end of 2030

  80% confidence

• The market will grow at a compound annual growth rate (CAGR) of 10.2% from 2025 to 2030

  80% confidence

• The transdermal route will show strong growth due to being non-invasive, painless and self-administrable

  80% confidence

• AI is revolutionizing the drug delivery system market by optimizing the entire development pipeline, from formulation design to clinical trial optimization

  80% confidence

Cited in these Via News reports

• Crypto Startups Block US Investors as $50B+ in Venture Capital Flows to Dubai, Japan, and El Salvador →
• Private Companies Now Take 20+ Years to IPO as Credit Facilities Replace Exit Liquidity →
• Venture LPs Turn to Collateralized Loans as Secondary Markets Demand 60% Discounts Globally →